Antiopoietin-related growth factor

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A01K 67/027 (2006.01) A61K 35/76 (2006.01) A61K 38/00 (2006.01) A61K 38/18 (2006.01) A61K 48/00 (2006.01) A61P 17/02 (2006.01) A61P 43/00 (2006.01) C07K 14/485 (2006.01) C07K 14/515 (2006.01) C12N 1/15 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2480419

It is intended to provide a mouse autologous growth factor (AGF) of human NL8/NEW which has been publicly known. Because of having an effect of promoting the growth of epidermal cells, AGF is useful as a wound healing agent or a tissue regenerating agent. It is also shown that a transgenic mouse with forced expression of AGF in epidermal cells is usable as a psoriasis model animal.

L'invention concerne un facteur de croissance autologue (AGF) connu de NL8/NEW humain. Du fait qu'il présente un effet de promotion de facteur de croissance de cellules épidermiques, on utilise AGF comme agent de cicatrisation de blessure ou comme agent de régénération tissulaire. On a également découvert qu'une souris transgénique dont l'expression d'AGF est forcée dans des cellules épidermiques peut être utilisée comme animal modèle du psoriasis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiopoietin-related growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiopoietin-related growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiopoietin-related growth factor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2054076

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.